tiprankstipranks
Immuneering Corp. Class A (IMRX)
NASDAQ:IMRX
US Market
IMRX
Immuneering
RESEARCH TOOLSreports
Want to see IMRX full AI Analyst Report?

Immuneering (IMRX) Ratios

665 Followers

Immuneering Ratios

IMRX's free cash flow for Q1 2026 was $0.00. For the 2026 fiscal year, IMRX's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 32.45 17.50 5.28 11.35 13.50
Quick Ratio
 32.45 17.50 5.28 11.35 13.50
Cash Ratio
 9.51 12.77 4.82 7.57 9.02
Solvency Ratio
 >-0.01 -4.10 -5.35 -4.42 -4.01
Operating Cash Flow Ratio
 >-0.01 -4.50 -7.33 -6.24 -5.48
Short-Term Operating Cash Flow Coverage
 -0.12 -114.19 0.00 0.00 0.00
Net Current Asset Value
$ 153.12B$ 162.74M$ 28.26M$ 77.08M$ 96.23M
Leverage Ratios
Debt-to-Assets Ratio
 0.02 0.02 0.08 0.04 0.04
Debt-to-Equity Ratio
 0.02 0.02 0.10 0.05 0.04
Debt-to-Capital Ratio
 0.02 0.02 0.09 0.05 0.04
Long-Term Debt-to-Capital Ratio
 0.02 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.04 1.06 1.27 1.13 1.11
Debt Service Coverage Ratio
 -0.14 -147.76 0.00 0.00 0.00
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
 19.68 <0.01 0.00 0.00 0.00
Interest Debt Per Share
 84.75 0.09 0.14 0.16 0.18
Net Debt to EBITDA
 740.66 2.13 0.50 0.95 1.32
Profitability Margins
Gross Profit Margin
0.00%0.00%0.00%0.00%50.11%
EBIT Margin
0.00%0.00%0.00%0.00%-16325.92%
EBITDA Margin
0.00%0.00%0.00%0.00%-16238.45%
Operating Profit Margin
0.00%0.00%0.00%0.00%-16325.77%
Pretax Profit Margin
0.00%0.00%0.00%0.00%-15937.44%
Net Profit Margin
0.00%0.00%0.00%0.00%-15937.29%
Continuous Operations Profit Margin
0.00%0.00%0.00%0.00%-15937.44%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
91.92%94.36%95.26%91.54%97.62%
Return on Assets (ROA)
-0.03%-24.15%-115.79%-52.12%-41.28%
Return on Equity (ROE)
-0.11%-25.64%-147.48%-59.03%-45.98%
Return on Capital Employed (ROCE)
-0.03%-26.76%-141.72%-61.66%-45.27%
Return on Invested Capital (ROIC)
-0.03%-26.71%-140.66%-61.46%-45.12%
Return on Tangible Assets
-0.03%-24.90%-133.64%-55.98%-43.82%
Earnings Yield
-23.70%-19.35%-92.54%-25.60%-39.47%
Efficiency Ratios
Receivables Turnover
 0.00 0.00 0.00 0.00 25.53
Payables Turnover
 <0.01 0.45 0.00 0.00 0.05
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.00 0.00 0.00 0.00 0.05
Asset Turnover
 0.00 0.00 0.00 0.00 <0.01
Working Capital Turnover Ratio
 0.00 0.00 0.00 0.00 <0.01
Cash Conversion Cycle
 -668.68K -805.71 0.00 0.00 -7.27K
Days of Sales Outstanding
 0.00 0.00 0.00 0.00 14.30
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 668.68K 805.71 0.00 0.00 7.28K
Operating Cycle
 0.00 0.00 0.00 0.00 14.30
Cash Flow Ratios
Operating Cash Flow Per Share
 -1.13 -1.03 -1.83 -1.72 -1.67
Free Cash Flow Per Share
 -1.13 -1.03 -1.84 -1.74 -1.70
CapEx Per Share
 <0.01 <0.01 <0.01 0.01 0.03
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.01 1.02
Dividend Paid and CapEx Coverage Ratio
 -233.09 -318.82 -648.01 -142.87 -59.40
Capital Expenditure Coverage Ratio
 -233.09 -318.82 -648.01 -142.87 -59.40
Operating Cash Flow Coverage Ratio
 -0.01 -11.86 -13.21 -10.97 -9.11
Operating Cash Flow to Sales Ratio
 0.00 0.00 0.00 0.00 -139.14
Free Cash Flow Yield
-26.34%-15.71%-83.51%-23.61%-35.04%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -4.22 -5.17 -1.08 -3.91 -2.53
Price-to-Sales (P/S) Ratio
 0.00 0.00 0.00 0.00 403.77
Price-to-Book (P/B) Ratio
 <0.01 1.33 1.59 2.31 1.17
Price-to-Free Cash Flow (P/FCF) Ratio
 -3.80 -6.37 -1.20 -4.24 -2.85
Price-to-Operating Cash Flow Ratio
 -4.62 -6.39 -1.20 -4.27 -2.90
Price-to-Earnings Growth (PEG) Ratio
 -0.08 0.14 -0.13 -7.30 -0.05
Price-to-Fair Value
 <0.01 1.33 1.59 2.31 1.17
Enterprise Value Multiple
 737.44 -2.81 -0.53 -2.65 -1.17
Enterprise Value
 -43.40B 164.78M 33.98M 153.92M 60.18M
EV to EBITDA
 737.44 -2.81 -0.53 -2.65 -1.17
EV to Sales
 0.00 0.00 0.00 0.00 189.87
EV to Free Cash Flow
 869.59 -3.62 -0.62 -3.12 -1.34
EV to Operating Cash Flow
 873.32 -3.63 -0.62 -3.14 -1.36
Tangible Book Value Per Share
 4.53K 4.80 1.15 2.94 3.89
Shareholders’ Equity Per Share
 4.69K 4.96 1.38 3.19 4.16
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 0.00 0.00 0.00 0.00 0.01
Net Income Per Share
 -1.24 -1.27 -2.04 -1.88 -1.91
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 0.91 0.94 0.95 0.92 0.98
Research & Development to Revenue
 0.00 0.00 0.00 0.00 114.42
SG&A to Revenue
 0.00 0.00 0.00 0.00 49.24
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.91 0.81 0.90 0.92 0.87
Currency in USD